New Blood Test Assesses Multiple SclerosiS Activity

Please join me for this ReachMD interview with Dr. William Kilgo, Neurology Residency Program Director, and Assistant Professor of Neurology, University of South Alabama, Mobile, AL, about his presentation at the 9th Annual ECTRIMS-ACTRIMS in Milan, IT, regarding the value of the multiple sclerosis disease activity test (MSDA). The MSDA is a multi-protein blood test that contains biomarkers regarding immunomodulation, inflammation, and neuron-axonal integrity. The score predicts MRI activity of multiple sclerosis.

Please listen here to this 8-minute program:

https://reachmd.com/programs/neurofrontiers/investigating-the-clinical-utility-of-the-multiple-sclerosis-disease-activity-test/16250/

To hear more interesting interviews, please tune in to "The Art of Medicine with Dr. Andrew Wilner," on YouTube and your favorite podcast player.

If you enjoy an episode of "The Art of Medicine with Dr. Andrew Wilner," please share it with friends and colleagues. "The Art of Medicine with Dr. Andrew Wilner" is now available on Alexa! Just say, "Play podcast The Art of Medicine with Dr. Andrew Wilner!"

To never miss a program, subscribe at www.andrewwilner.com. You'll learn about new episodes and other exciting programs I host on Medscape.com, ReachMD.com, and RadioMD.com.

Please rate and review each episode.

To contact Dr. Wilner: www.andrewwilner.com.